BioSpace News Archive

Lily Bioceuticals™ CEO Michael Kruel reports, “We’ve provided women over 40 with a much younger-looking face on which to apply make-up and it lasts an entire day and night.

IQVIA™ (NYSE: IQV) announced today that its Linguamatics Natural Language Processing (NLP) platform has been selected as the winner in Questex’s 2019 Fierce Innovation Awards — LifeSciences Edition in the Data Analytics/Business Intelligence category.

VentureMed Group, Inc., a privately-held medical device innovator focused on vessel preparation for interventional treatment of peripheral arterial disease (PAD) and stenoses of arteriovenous (AV) fistulas and grafts, announced data presented at the International Symposium on Intervascular Therapy (ISET) Annual Conference, Jan. 22-24, in Hollywood, Florida.

Recent clinical studies presented at International Symposium organized by Fondazione Internazionale Menarini The World Health Organization warns: invest more and invest now in research to avoid catastrophic consequences for public health [30-January-2020] FLORENCE, Italy , Jan. 30, 2020 /PRNewswire/ -- The introduction of new antibiotics would reduce the num

Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced that the Company plans to release a benchtop, R&D scale, Ultra Shear Technology™ (“UST™")-based BaroShear instrument to the market in the third quarter of 2020

Nihon Kohden, a U.S. market leader in precision medical products and services, today announced the commercial launch of its new NKV-550 Series Ventilator System, which offers a full suite of applications necessary in a critical care setting for patients of all ages – from neonate through adult.

Chiesi USA, Inc. (key-A-zee) announced today that the company has been named as a Top Employer in the United States for the fifth consecutive year

Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce that its wholly-owned subsidiary, Natural MedCo Ltd. (“Natural MedCo”), has entered into an exclusive letter of intent (the “LOI”) with ECS BioMed Inc. (“Dr. Kerklaan Therapeutics”) effective January 14, 2020.

RightEye LLC, an award-winning health technology company using eye tracking to help diagnose health and vision issues as well as improve performance vision, today announced the publication of a study, co-authored by RightEye co-founder and Chief Science Officer Dr. Melissa Hunfalvay,

Greenphire, the global leader in financial software for clinical trials, today announced that its CEO, Jim Murphy, will co-present alongside Lazarex Cancer Foundation Founder, Dana Dornsife, at the Society for Clinical Research Sites (SCRS)'s annual Global Oncology Site Solutions Summit.